Should I buy Equifax (EFX) stock or is it too late?

Equifax · Industrials · price $190

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Mizuho — 72% of its targets hit on this sector (120 calls tested). It aims for $210 (+10 %), call made on July 3, 2026, maturing on July 3, 2027 (56 d ago).

The 8 reliable analysts $216+14 %

The 2 other firms $230+21 %

How to read it: the 8 reliable firms are not filtered by optimism — 8 aim above the price, 0 below, hence their $216 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Equifax

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	65 %	+11.1 %	23	$200 +5%
JP Morgan	58 %	+8.6 %	12	$230 +21%
Baird	54 %	+5.2 %	13	$232 +22%
Stifel	50 %	+3.5 %	10	$235 +23%
Needham	38 %	+1.0 %	21	$245 +29%
B of A Securities	0 %	-8.9 %	6	$225 +18%
Wells Fargo	33 %	-9.1 %	15	$212 +11%
Morgan Stanley	27 %	-9.9 %	11	$225 +18%

In short — Should you invest in Equifax? Is it too late, still worth it? Analysts are overwhelmingly positive (90% buy, median target $223, i.e. +17%), and the most reliable on EFX targets even higher. But the valuation is stretched (P/E ~33). We give you both sides, with the numbers — not advice.

✅ Reasons to believe

90% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
Median price target $223, i.e. +17% from the current price ($190).
The most reliable firm on EFX, Goldman Sachs (75% hit rate, 4 scored calls), targets $208 (call made on February 9, 2026, maturing on February 9, 2027) (+9%) in its most recent call.
6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 10 ratings, 1 is neutral.
High valuation (P/E ~33): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on EFX

Median target $223 (+17%) · 10 ratings · Buy consensus

Strong Buy00%

Buy990%

Hold110%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Equifax now?

We won't decide for you. The facts: 90% of analysts rate it a buy, median target $223 (+17%), and Goldman Sachs (most reliable on EFX, 75%) targets $208. Weigh that against valuation (P/E ~33). This is not personalized advice.

Is it too late to invest in Equifax?

Not according to analysts: the median target ($223) is still +17% above the current price ($190) (most reliable on EFX: Goldman Sachs, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Equifax still worth investing in?

It depends on the gap between the price ($190) and its estimated value: analysts target $223 on median (+17%), with 90% buys (most reliable on EFX: Goldman Sachs, 75%). Cross-check with their real reliability on EFX and the cautions above. Information, not advice.

What's the main risk in buying EFX?

The consensus is not unanimous: of 10 ratings, 1 is neutral.

→ Go deeper: the full Equifax profile (consensus, analyst reliability, price target, performance).